Monthly Archives: March 2019

Creator of Fraudulent Pharmacy Sentenced to 5 Years in Prison – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Creator of Fraudulent Pharmacy Sentenced to 5 Years in Prison – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 A fraudulent Chicago-area pharmacy creator has been sentenced to … Continue reading

Posted in Pharmacist | Tagged , , , | Leave a comment

Match Day Pairs Thousands of Pharmacy Students With Residency Programs – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Match Day Pairs Thousands of Pharmacy Students With Residency Programs – APhA submits compounding comments to FDA. – (866) 348-2889. March 15 marks Match Day, in which thousands of student pharmacists from across … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Influenza Activity in the United States Slightly Decreased – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Influenza Activity in the United States Slightly Decreased – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Influenza activity has been decreasing in recent weeks, but remains elevated … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Inserts Containing Combination Therapy May Protect Women Against HIV – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Inserts Containing Combination Therapy May Protect Women Against HIV – APhA submits compounding comments to FDA. – (866) 348-2889. Vaginal inserts containing tenofovir alafenamide fumarate (TAF) in combination with elvitegravir (EVG) may … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Texas Compounder Ordered to Stop Production by Federal Court – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Texas Compounder Ordered to Stop Production by Federal Court – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 A federal judge has ordered Guardian Pharmacy Services, a Texas-based … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Officials OK New Generic Valsartan – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Officials OK New Generic Valsartan – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the US Food and Drug Administration have approved a new generic of Diovan (valsartan), … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

Fourth Trastuzumab Biosimilar Granted FDA Approval – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF Fourth Trastuzumab Biosimilar Granted FDA Approval – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Officials with the FDA have approved trastuzumab-qyyp (Trazimera, Pfizer), a biosimilar to trastuzumab … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Grants Breakthrough Designation to Chemotherapy-Free Combo Therapy for CLL – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Grants Breakthrough Designation to Chemotherapy-Free Combo Therapy for CLL – APhA submits compounding comments to FDA. – (866) 348-2889. Genentech and AbbVie have announced the submission of the supplemental New Drug … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA OKs Esketamine Nasal Spray for Treatment-Resistant Depression – Drug for nerve pain boosts high for opioid abusers.

Aabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA OKs Esketamine Nasal Spray for Treatment-Resistant Depression – Drug for nerve pain boosts high for opioid abusers. (866) 348-2889 Officials with the FDA have approved esketamine CIII nasal spray (Spravato, … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off

FDA Accepts Supplemental New Drug Application for Baloxavir Marboxil for Treating Flu in People at High Risk of Complications – APhA submits compounding comments to FDA.

Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF FDA Accepts Supplemental New Drug Application for Baloxavir Marboxil for Treating Flu in People at High Risk of Complications – APhA submits compounding comments to FDA. – (866) 348-2889. Officials with the … Continue reading

Posted in Pharmacist | Tagged , , , | Comments Off